IDA only vs Rwanda: Access to anti-retroviral drugs, male
IDA only
80.4%
in 2024
Rwanda
95.0%
in 2024
IDA only rank
4th
Rwanda rank
4th
Access to anti-retroviral drugs, male over time
- IDA only
- Rwanda
How they compare
Rwanda currently reports 95.0% against 80.4% in IDA only, a difference of 14.6%.
That makes Rwanda's figure about 1.2 times IDA only's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Rwanda ahead.
IDA only ranks 4th and Rwanda ranks 4th of 19 groups.
Rwanda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA only | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.7% | 10.4% | 4.7% | Rwanda |
| 2010s | 39.9% | 60.0% | 20.1% | Rwanda |
| 2020s | 73.0% | 90.0% | 17.0% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, IDA only or Rwanda?
- Rwanda, at 95.0% against 80.4% in IDA only as of 2024.
- What is the difference in access to anti-retroviral drugs, male between IDA only and Rwanda?
- 14.6%, with Rwanda ahead.
- How many years of comparable data are there for IDA only and Rwanda?
- 25 years are reported by both, from 2000 to 2024.
- How do IDA only and Rwanda rank globally for access to anti-retroviral drugs, male?
- IDA only ranks 4th and Rwanda ranks 4th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.